Investigating why some patients with chronic lymphocytic leukemia resist treatment with BTK inhibitors
Understanding mechanisms of BTK inhibitor and degrader resistance in patients with chronic lymphocytic leukemia
This study is looking into why some people with chronic lymphocytic leukemia (CLL) don’t respond to certain medications called BTK inhibitors, with the goal of finding better treatment options for those who struggle with these therapies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-10943869 on NIH RePORTER |
What this research studies
This research focuses on understanding why some patients with chronic lymphocytic leukemia (CLL) do not respond to BTK inhibitors, which are designed to treat B-cell malignancies. The team will explore the molecular mechanisms behind resistance to these treatments, including studying specific mutations in the BTK gene and other related pathways. By identifying these resistance mechanisms, the researchers aim to develop better treatment strategies that could include new drug combinations. This work is crucial for improving outcomes for patients who experience treatment failure.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with chronic lymphocytic leukemia who have experienced resistance or intolerance to BTK inhibitors.
Not a fit: Patients who do not have chronic lymphocytic leukemia or those who have not been treated with BTK inhibitors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with chronic lymphocytic leukemia who currently struggle with resistance to existing therapies.
How similar studies have performed: Previous research has shown promise in understanding resistance mechanisms in cancer therapies, making this approach both relevant and potentially impactful.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Taylor, Justin — University of Miami School of Medicine
- Study coordinator: Taylor, Justin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.